Home » Topics » BioWorld Science

BioWorld Science
RSS

Zinc oxide nanoparticles target integrin alpha-v beta-3 for breast cancer treatment

March 9, 2022

TNIK Therapeutics presents new prodrugs of TNIK inhibitors

March 9, 2022

P2RX3 antagonists discovered at Tuojie Biotech

March 9, 2022

Nanjing Shunxin Pharmaceutical, Jiangsu Chia Tai Tianqing Pharmaceutical Group patent ADCs

March 9, 2022

New ibuprofen derivatives divulged by Nanjing Heron Pharmaceutical Science and Technology

March 9, 2022

Abbisko Therapeutics identifies new EGFR inhibitors

March 9, 2022

Ixaka's CELTIC-19 targeted nanoparticle product granted ATMP classification

March 8, 2022

Sunshine Lake Pharma researchers describe JAK inhibitors

March 8, 2022

Dana-Farber Cancer Institute patents USP28 inhibitors for cancer

March 8, 2022

Bridge signs option agreement for CellionBioMed's ion channel modulator for IPF

March 8, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...